as one for which the drug-release characteristics of time course and/or location are chosen to accomplish therapeutic or convenience objectives not offered by conventional dosage forms such as solutions, ointments, or promptly dissolving dosage forms as presently recognized.Several types of modified-release drug products are recognized:
1. Extended-release drug products. A dosage form that allows at least a twofold reduction in dosage frequency as compared to that drug presented as an immediate-release (conventional) dosage form. Examples of extended-release dosage forms include controlled-release, sustained-release, and long-acting drug products.
2. Delayed-release drug products. A dosage form that releases a discrete portion or portions of drug at a time or at times other than promptly after administration, although one portion may be released promptly after administration. Enteric-coated dosage forms are the most common delayed-release products. See example here.
3. Targeted-release drug products. A dosage form that releases drug at or near the intended physiologic site of action. Targeted-release dosage forms may have either immediate- or extended-release characteristics.
The term controlled-release drug product was
previously used to describe various types of oral extended-release-rate dosage
forms, including sustained-release, sustained-action, prolonged-action,
long-action, slow-release, and programmed drug delivery. Other terms, such as
ER, SR, XL, XR, and CD, are also used to indicate an extended-release drug
product. Many of these terms for modified-release drug products were introduced
by drug companies to reflect either a special design for an extended-release
drug product or for use as a marketing term.
Modified-release drug products are designed for different
routes of administration based on the physicochemical, pharmacologic, and
pharmacokinetic properties of the drug and on the properties of the materials
used in the dosage form. Several different terms are now defined to describe
the available types of modified-release drug products based on the drug release
characteristics of the products.
No comments:
Post a Comment